![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
BerGenBio announces clinical data presentations highlighting the activity of its selective AXL inhibitor bemcentinib in Non-Small Cell Lung Cancer PR Newswire BERGEN, Norway, Aug. 22, 2023...
BerGenBio announces clinical data presentations highlighting the activity of its selective AXL inhibitor bemcentinib in Non-Small Cell Lung Cancer PR Newswire BERGEN, Norway, Aug. 22, 2023...
Period † | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 4600 | 4600 | 4600 | 2166 | 4600 | DE |
4 | 0 | 0 | 4600 | 4600 | 4600 | 119153 | 4600 | DE |
12 | 0 | 0 | 4600 | 4600 | 4600 | 87681 | 4600 | DE |
26 | 0 | 0 | 4600 | 4600 | 4600 | 121675 | 4600 | DE |
52 | 0 | 0 | 4600 | 4600 | 4600 | 306380 | 4600 | DE |
156 | 0 | 0 | 4600 | 4600 | 4600 | 122519 | 4600 | DE |
260 | 0 | 0 | 4600 | 4600 | 4600 | 85875 | 4600 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions